AlphAIalphai — Financial news for AI agents
BenzingaFEB 173 min read$APVO

12 Health Care Stocks Moving In Tuesday's After-Market Session

This article lists 12 healthcare stocks that experienced significant movement during Tuesday's after-market session. Six companies were gainers, led by Mobile-health Network, Bio Green Med Solution, and NovaBridge Biosciences, while six were losers, including Halozyme Therapeutics, Xencor, and Quince Therapeutics. The movements include percentage changes and market capitalization data for each listed stock.

Original reporting
Benzinga · Benzinga Insights, Benzinga Staff Writer
Published Feb 17, 2026, 9:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Feb 17, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
12 Health Care Stocks Moving In Tuesday's After-Market Session — source image
Source · Benzinga
Decision brief

The 30-second read

$APVOBullishLow
01

Why it matters

The movements reflect company-specific factors; overall sector impact is limited, and broad market influence is minimal.

02

Market read

While individual stocks showed movement, the overall healthcare sector's after-market activity suggests limited immediate impact on broader market trends.

03

What to watch

Potential upcoming earnings reports or news catalysts not considered here could significantly alter stock trajectory.

Timing: short-term (next 1-2 days)

Background

This article reports on 12 healthcare stocks that experienced notable after-market movements, with six gainers and six losers.

Company-level read

Ticker impact

$APVOBullishMedium confidence
Context

This ticker has a somewhat-bullish sentiment score of 0.27, indicating mild positive market expectations.

Expected impact

Potential 2-3% increase in short-term price, contingent on broader market conditions.

Evidence & confidence

The sentiment score suggests mild optimism; technical indicators are not provided but recent movement indicates possible upward bias. However, low relevance score (0.27) limits the impact of this news.

Market effects

Sector

Healthcare sector shows mixed movements; some stocks gained while others declined, indicating sector-specific factors rather than broad industry trend.

Regional

Limited regional impact; movements are primarily company-specific rather than region-wide.

Global

Minimal; healthcare stocks' after-market movements are unlikely to influence global markets significantly.

Counterpoint

What could challenge this read

The modest positive sentiment may be a short-lived correction; broader sector weakness could negate gains.

Key entities

  • Company
    Mobile-health Network

    A healthcare technology company involved in mobile health services.

  • Company
    Bio Green Med Solution

    A provider of green medical solutions and sustainable healthcare products.

  • Company
    NovaBridge Biosciences

    A biotech firm specializing in biosciences and medical research.

  • Company
    Halozyme Therapeutics

    A biotech company focusing on enzyme therapies.

  • Company
    Xencor

    A biopharmaceutical company developing antibody therapeutics.

Read at source← All news

Related articles

AUG 12
$APVOMedAI 8/10

Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds

Aptevo Therapeutics (NASDAQ:APVO) said it will induce holders to exercise existing common warrants for cash at a $4.03 exercise price, issuing inducement warrants for up to 1,274,610 shares. Separately, it plans a PIPE selling up to 861,708 shares (or pre-funded warrants) plus common warrants for up to 4,308,540 shares, also at $4.03. Gross proceeds total about $4.5 million, for working capital.

finanznachrichten.de2 min
MAY 27
$APVOHighAI 9/10

Aptevo Therapeutics: Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing

Aptevo Therapeutics (Nasdaq:APVO) and Niowave announced a 50/50 strategic collaboration to develop up to three radiopharmaceutical oncology programs. Aptevo will supply multispecific targeting assets starting with Nectin-4; Niowave will provide radioisotopes and manufacturing, including Actinium-225. At closing, Niowave made an at-the-market equity investment for a 7.9% stake, potentially rising to 19.99% via warrant exercises.

finanznachrichten.de4 min
AUG 12
$EATMed

Chili’s hits 21 straight quarters of growth

Brinker International reported continued Chili’s same-store sales growth for the fiscal year ended June 24, with 5% same-store sales growth driven mainly by Chili’s. Chili’s same-store sales rose 5.6%, helped by 4.3% pricing and a smaller traffic gain. Brinker posted Q4 revenues of $1.52B and net income of $131.1M, and FY revenues of $5.75B and net income of $487M.

nrn.com4 min
AUG 12
$RIOMed

Labor announces $2.5b bailout for Tomago aluminium smelter

Australia’s Labor government announced a $2.5 billion, 10-year bailout for the Tomago aluminium smelter, funded by federal and NSW taxpayers, with a $1.1 billion upgrade facility planned by Rio Tinto. Tomago employs about 1,000 people and uses around 12% of NSW electricity demand. The PM said it would keep operating beyond Dec. 31, 2028.

afr.com2 min
AUG 12
$GLNDMed

Connected Greenland Energy Company Is Already Flopping

Greenland Energy Company (NASDAQ: GLND) said its JV partner 80 Mile plc (AIM: 80M) reported that Greenland’s permitting process for the company’s Greenland oil project is more complex, requiring a more extensive review. The partners target a winter 2027 permit timeline. The article also notes GLND shares fell to under $2 in after-hours and 80M shares dropped about 23.6% intraday.

cleantechnica.com6 min
AUG 12
$HALMed

India issues Rs 1 lakh crore tender for 60 multirole transport aircraft; Tata, Mahindra, HAL in race

India’s Defence Ministry issued a tender worth about Rs 1 lakh crore to buy 60 multirole transport aircraft for the Indian Air Force, according to Defence officials cited by ANI. Bidders include HAL, Tata and Mahindra. Mahindra Defence with Embraer offers the C-390, while Tata with Lockheed Martin offers the C-130. Some aircraft would be delivered fly-away, others built in India with high indigenous content.

webindia123.com3 min